Detailed SWOT Analysis Report: Malaysian Clinics Market Overview

This report presents a SWOT (Strengths, Weaknesses, Opportunities, and Threats) analysis of the Malaysian clinics market. The strengths identified include supportive government policies, improving local assembly standards, and the growth of the medical market. Weaknesses include lax patient laws, low-quality local medicine, and a lack of promotional activities. Opportunities include the growth of medical tourism and the adoption of Western administrative models. Threats encompass counterfeit drugs, the impact of government drug evaluation strategies, and import dependencies. The analysis also highlights the need for licenses and patent rights. The report references several studies to support its findings, providing a comprehensive overview of the Malaysian clinics' business environment and market dynamics.

Running head: SWOT ANALYSIS 1
SWOT ANALYSIS

Running head: SWOT ANALYSIS
Strengths
The international investments were attracted
with the assistance of the dynamic
government policy and the guidelines.
Improving nearby assembling principles,
with a promise of the biotech advancement is
also one of the strength of the clinics in the
Malaysia.
Due to the acceleration of the medical market
in the recent years in Malaysia, there is a
wide range of the competition (Ahmadi,
Ibrahim & Nilashi, 2015).
Due to the centralized system the clinics in
Malaysia are able to cater the customers with
new services.
Due to the non-presence of the controlling
prices in the private sector the clinics in
Malaysia are able to flourish more.
Sizeable generics showcase, given low
patient buying power and lax patent laws
Endorsing and administering by and by
managed by general professionals, boosting
in general estimations of the medicine
showcase
OTC and generics markets are set to become
emphatically throughout the following nine
to ten years down the line.
Weakness
With the strength comes the weakness where
the law for the lax patients is constantly
below the belt and there seems no
improvement.
Due to the local manufacturing the clinics are
giving the low quality and inexpensive
medicines to the customers.
Late change went for expanding
nonexclusive item improvement exacerbating
activity conditions for multinationals
Severe government medicate evaluating
strategy vigorously one-sided towards nearby
medication makers
Market dependent on imports, especially at
the hey tech end of scale, influencing
government funds
The innovations are less and in this
competitive world the diversification is what
the clinics lack in Malaysia
The lack of the promotional activities is also
one of the critical weakness, unlike in
Thailand and India (Abolfazli, et al 2015).
Opportunities
Medical tourism comprises of the clinics and
hospitals as well. Therefore with the correct
policies and the procedures the market of the
clinics can grow.
Malaysia tends to become one of the popular
subjects in the field of the medicines and
tourism.
ASEAN harmonization empowering the
appropriation of Western administrative
models and the improvement of intra-
territorial exchange (Risso-Gill, et al 2015).
Threats
The presence of the counterfeit drug centre
could lead to the potential threats for the
clinic market.
Severe government medicated evaluating
strategy are adopted vigorously only from
one-sided towards nearby medication makers.
This brings the gap between the medicine
makers and the clinics (Teh, et al 2015).
Market dependent on imports, especially at
the high tech end of scale, influencing
government funds and the cost of the
medicines.

Running head: SWOT ANALYSIS
Interest in the biotech part improvement
bolstered by government activities
Malaysia turning into an appealing area for
medicinal the travel industry
Arranged interest in the extension of
medicinal offices
There is a need of the license to operate and
along with that for certain patented rights.

Running head: SWOT ANALYSIS
References
Abolfazli, S., Sanaei, Z., Tabassi, A., Rosen, S., Gani, A., & Khan, S. U. (2015). Cloud
adoption in Malaysia: Trends, opportunities, and challenges. IEEE Cloud
Computing, 2(1), 60-68.
Ahmadi, H., Ibrahim, O., & Nilashi, M. (2015). Investigating a new framework for hospital
information system adoption: a case on Malaysia. Journal of Soft Computing and
Decision Support Systems, 2(2), 26-33.
Risso-Gill, I., Balabanova, D., Majid, F., Ng, K. K., Yusoff, K., Mustapha, F., ... & Teo, K.
K. (2015). Understanding the modifiable health systems barriers to hypertension
management in Malaysia: a multi-method health systems appraisal approach. BMC
health services research, 15(1), 254.
Teh, Y. C., Tan, G. H., Taib, N. A., Rahmat, K., Westerhout, C. J., Fadzli, F., ... & Yip, C. H.
(2015). Opportunistic mammography screening provides effective detection rates in a
limited resource healthcare system. BMC cancer, 15(1), 405.